← Leaderboards
Michael Nathan Vansaun
University Of Kansas Medical Center
$1,883,647
Attributed
$1,883,647
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $349.4K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,883,647 · 2
By mechanism
R01$1,728,647 · 1
R03$155,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Scott James Weir$2,961,565
Others in their field
Other Emerging Leaders on “Tumorigenic”
- Richard Joseph Johnson · Colorado Research Partners, Llc$6,102,731
- Kian H Lim · Washington University$4,799,877
- Brooke M Emerling · Sanford Burnham Prebys Medical Discovery Institute$4,446,740
- Nada Y. Kalaany · Boston Children'S Hospital$3,668,850
- Miyeko Mana · Arizona State University-Tempe Campus$3,591,646
- Tamer M A Mohamed · Baylor College Of Medicine$3,187,572
Research focus
TumorigenicRisk FactorsReceptorTumorRecruitResistanceIn VivoNeoplastic CellObese MicePancreatic Ductal AdenocarcinomaInflammationGrowthAdipose TissueImmuneCxcl5 GeneIn VitroMolecularMalignant Neoplasm Of PancreasDesignCytokineCellsObesityGenetically Engineered MouseTumor Microenvironment
Grant awards (8)
Enhancing intratumoral T cell infiltration by deliver of shCXCL5 in a Plectin targeted AAV to improve checkpoint blockade efficacy$77,500
R03 · FY2025 · CA · contact PI
Enhancing intratumoral T cell infiltration by deliver of shCXCL5 in a Plectin targeted AAV to improve checkpoint blockade efficacy$77,500
R03 · FY2024 · CA · contact PI
Counteracting molecular mechanisms of obesity dependent PDAC progression$341,323
R01 · FY2023 · CA · contact PI
Counteracting molecular mechanisms of obesity dependent PDAC progression$341,322
R01 · FY2022 · CA · contact PI
Counteracting molecular mechanisms of obesity dependent PDAC progression$348,288
R01 · FY2021 · CA · contact PI
Counteracting molecular mechanisms of obesity dependent PDAC progression$348,288
R01 · FY2020 · CA · contact PI
Counteracting molecular mechanisms of obesity dependent PDAC progression$258,716
R01 · FY2019 · CA · contact PI
Counteracting molecular mechanisms of obesity dependent PDAC progression$90,710
R01 · FY2019 · CA · contact PI